These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors. Rotstein R; Landau T; Twig A; Rubinstein A; Koffler M; Justo D; Constantiner D; Zeltser D; Shapira I; Mardi T; Goldin Y; Berliner S Atherosclerosis; 2002 Dec; 165(2):343-51. PubMed ID: 12417286 [TBL] [Abstract][Full Text] [Related]
25. Capillary and venous leukocyte adhesiveness/aggregation to differentiate between viral and bacterial infection. Rotstein R; Kassirer M; Zeltser D; Maharshak N; Mardi T; Avitzour D; Shapira I; Justo D; Arber N; Berliner S Infection; 2002 Dec; 30(6):365-72. PubMed ID: 12478327 [TBL] [Abstract][Full Text] [Related]
26. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease. Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749 [TBL] [Abstract][Full Text] [Related]
27. The nondietary determinants of vitamin D status in pediatric inflammatory bowel disease. Veit LE; Maranda L; Nwosu BU Nutrition; 2015; 31(7-8):994-9. PubMed ID: 26059374 [TBL] [Abstract][Full Text] [Related]
29. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482 [TBL] [Abstract][Full Text] [Related]
30. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease. Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251 [TBL] [Abstract][Full Text] [Related]
31. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692 [TBL] [Abstract][Full Text] [Related]
32. Higher levels of CCL20 expression on peripheral blood mononuclear cells of chinese patients with inflammatory bowel disease. He C; Zhang SL; Hu CJ; Tong DW; Li YZ Immunol Invest; 2010; 39(1):16-26. PubMed ID: 20064082 [TBL] [Abstract][Full Text] [Related]
33. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984 [TBL] [Abstract][Full Text] [Related]
34. Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous. Sawada K; Takahashi R; Saniabadi AR; Ohdo M; Shimoyama T World J Gastroenterol; 2006 Mar; 12(10):1621-5. PubMed ID: 16570358 [TBL] [Abstract][Full Text] [Related]
35. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse. Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363 [TBL] [Abstract][Full Text] [Related]
36. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922 [TBL] [Abstract][Full Text] [Related]
37. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165 [TBL] [Abstract][Full Text] [Related]
38. Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse. Maiden L; Takeuchi K; Baur R; Bjarnason I; O'Donohue J; Forgacs I; Chung-Faye G; Sanderson J; Bjarnason I Inflamm Bowel Dis; 2008 Oct; 14(10):1413-8. PubMed ID: 18521900 [TBL] [Abstract][Full Text] [Related]
39. [Serum calgranulin C is a highly sensitive autoinflammation activity indicator in patients with familial periodic fevers]. Bogdanova MV; Rameev VV; Kozlovskaya LV; Fedorov ES; Salugina SO Ter Arkh; 2016; 88(6):58-64. PubMed ID: 27296263 [TBL] [Abstract][Full Text] [Related]
40. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission. Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]